APP and Alzheimer disease: Improvements in cognition were observed in APP/PS1 AD mice fed with HT acetate (50 mg/kg/day) by the ameliorating of electrophysiological dysfunction of neurons and brain inflammation through the modulation of NF-κB activity and mitogen-activated protein kinase (MAPK) signaling [52].